| row-start col-xs-12 row-end no-pad-bottom-section #top-section top-section new-section |
| row-start col-xs-12 row-end agenda-section |
10/20/2022
| Central Park | |
| 9:00 am - 9:40 am | Genome Editing Panel (Public Co’s) [More Info] |
| 9:45 am - 10:25 am | Genome Editing Panel (Private Co’s) [More Info] |
| 10:30 am - 10:55 am | Q&A Panel with George Church, Ph.D. (Harvard, Wyss Institute) [More Info] |
| Meeting - Q&A Panel with George Church, Ph.D. | |
| 10:55 am - 11:10 am | Break |
| 11:10 am - 12:05 pm | RNA Editing Panel [More Info] |
| 12:05 pm - 12:15 pm | Break |
| 12:15 pm - 1:10 pm | Regulatory/Chemistry Manufacturing & Controls Panel (Lunch) [More Info] |
| 1:15 pm - 2:10 pm | Rare/Non-Rare Disease Panel [More Info] |
| 2:10 pm - 2:20 pm | Break |
| 2:20 pm - 3:15 pm | CNS Panel [More Info] |
| Meeting - CNS Panel |
| Companies Hosting Meetings Only | |||
| Company | Ticker | Company Management | Date(s) Hosting Meetings |
| Adverum Biotechnologies, Inc. | ADVM | Anand Reddi, VP, Corporate Strategy, External Affairs and Engagement | 10/20/2022 |
| Editas Medicine, Inc. | EDIT | Gilmore O'Neill, CEO Ron Moldaver, Investor Relations | 10/20/2022 |
| Intellia Therapeutics | NTLA | Lucas Buchheim-Jurisson, Corproate Strategy David Lebwohl, Chief Medical Officer Lina Li, Senior Director, Investor Relations & Corporate Communications Ian Karp, SVP, Investor Relations & Corporate Communications | 10/20/2022 |
| Krystal Biotech, Inc. | KRYS | Krish Krishnan, Chairman and CEO Meg Dodge, Head of Investor Relations and Corporate Communications | |
| Passage Bio, Inc | PASG | Chip Cale, Interim CEO and General Counsel Simona King, CFO Stuart Henderson, VP, Corporate Development and Investor Relations | 10/20/2022 |
| PTC Therapeutics, Inc. | PTCT | Matthew Klein, Chief Operating Officer Ronald Aldridge, Senior Director, Investor Relations Kylie O'Keefe, SVP, Commercial and Corporate Strategy | |
| Verve Therapeutics | VERV | Peter Smith, CEO and Co-Founder Alex Harding, SVP, Business Development and Corporate Strategy Ashley Porras, Sr. Manager, Business Development and Corporate Strategy Ilan Ganot, President and Chief Executive Officer Bo Cumbo, CEO of Aavanti Bio Andrew Bellinger, Chief Scientific Officer and Chief Medical Officer Jen Robinson, IR | 10/20/2022 |
| Voyager Therapeutics | VYGR | Al Sandrock, CEO | |
| Wave Life Sciences | WVE | Paul Bolno, President and CEO Kate Rausch, VP, Investor Relations and Corporate Affairs | 10/20/2022 |
